Form 8-K - Current report
SEC Accession No. 0001645113-26-000071
Filing Date
2026-10-01
Accepted
2026-10-01 09:00:29
Documents
12
Period of Report
2026-10-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20261001.htm   iXBRL 8-K 24811
2 EX-99.1 paxjapandecisionpr.htm EX-99.1 17514
  Complete submission text file 0001645113-26-000071.txt   163717

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20261001.xsd EX-101.SCH 1882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20261001_lab.xml EX-101.LAB 21801
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20261001_pre.xml EX-101.PRE 12579
15 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20261001_htm.xml XML 2707
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Jersey
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Jersey 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 261429142
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)